Terry
Thank you for your excellent comments-well put

Thanks,

Mary Ann Daly, RN BSN CCRN DC
Regional Lead-Sepsis
Gordon and Betty Moore Foundation Grant
Sutter Health Sacramento Sierra Region
E-mail: [email protected]<mailto:[email protected]>
Blackberry: 916.200.5604   Office: 916.614.6370

Please consider the environment before printing this e-mail
IMPORTANT CONFIDENTIALITY NOTICE: This E-mail (including any documents referred 
to in, or attached, to this E-mail) is intended only for the name addressee may 
contain information that is personal, confidential/privileged or the subject of 
copyright or other proprietary rights in favor of Sutter Health, its affiliates 
or third parties. If you received this E-mail by mistake you should: (1) not 
copy, disclose, distribute or otherwise use it, or its contents, without the 
consent of Sutter Health or the owner of the relevant rights; (2) let us know 
of the mistake by reply E-mail or by telephone (916.453.5121); and (3) delete 
it from your system and destroy all copies.
Any personal information contained in this E-mail must be handled in accordance 
with applicable privacy laws.

From: [email protected] 
[mailto:[email protected]] On Behalf Of Terry Clemmer
Sent: Thursday, December 15, 2011 7:53 AM
To: [email protected]; [email protected]; 
[email protected]
Cc: Terry Clemmer
Subject: Re: [Sepsis Groups] Paul E. Marik

Quality improvement is always about change. It is important to build that into 
our systems so when new information becomes available we can continue to grow 
and improve. We saw this with the "Nice-Sugar" and with "Corticus" 
publications, and now with the demise of rAPC availability. When the "ProCess" 
study finishes we may see it again. The same is now ongoing with new challenges 
to the use of the CVP measurement as new technologies are being developed. The 
sepsis bundle is not sacred. That is why the SSC revises the guidelines on a 
regular basis, 2004, 2008 and now 2012.

Don't despair this again is and opportunity to make it better. Focus on 
building robust systems of change that can deal with these changes with less 
effort and pain. Be careful however, to not jump to quickly on every new 
publication, it sometimes take time until new concepts are truly validated. 
Tight glucose control is an example. At other times certain concepts never die, 
ECMO is one of them in which the benefit has never been proven in good 
randomized studies but continues to grow in popularity anyway.

Terry P. Clemmer, MD
Director of Critical Care Medicine
LDS Hospital,
8th Ave and 'C' Street
Salt Lake City, Utah 84143

Phone 801-408-3661
E-mail: [email protected]<mailto:[email protected]>


"Confidential Report for Improvement of Hospital, Facility and Patient 
Care--Not Part of Medical Record and Not to be Used in Litigation--Prepared 
Pursuant to Utah Code Ann. § 26-25-1 et seq., or Idaho Code Ann. § 39-1392 et 
seq."

From: 
[email protected]<mailto:[email protected]>
 [mailto:[email protected]] On Behalf Of 
[email protected]<mailto:[email protected]>
Sent: Friday, December 09, 2011 8:54 AM
To: [email protected]<mailto:[email protected]>; 
[email protected]<mailto:[email protected]>
Subject: Re: [Sepsis Groups] Paul E. Marik

I received the article from one of our ED physicians and physician champion for 
our sepsis campaign.  So I feel your pain. It hasn't helped me move this 
project forward!



Susan M. McKinney RN
eICU®/Sepsis Quality Coordinator
Clinical Effectiveness Team
Rapid City Regional Hospital
605-390-1679
Pager 1725



From: 
[email protected]<mailto:[email protected]>
 [mailto:[email protected]] On Behalf Of Carina 
Idiesca
Sent: Thursday, December 08, 2011 10:50 PM
To: sepsis family
Subject: [Sepsis Groups] Paul E. Marik

Dear All,

I would like to ask for a feedback regarding an article authored by Paul E. 
Marik which was published in the Annals of Intensive Care 2011 1:17. The 
article is entitled " Surviving sepsis:going beyond the guidelines". Much to my 
chagrin, it contained unfavorable reviews of the SSC bundles.

Hoping to hear from you all,
Carina
MD. USA

PS
Since the NICE-SUGAR study, is the majority still using intensive insulin 
therapy drip for hyperglycemia in the ICU patients? Our pharmacist shared an 
article (details & source to follow, apologies) regarding the use of insulin 
drip to treat hyperglycemia as a weak recommendation.

Thanks.



________________________________

Regional Health's mission is to provide and support health care excellence in 
partnership with the communities we serve.

Note: The information contained in this message, including any attachments, may 
be privileged, confidential, or protected from disclosure under state or 
federal laws . If the reader of this message is not the intended recipient, or 
an employee or agent responsible for delivering this message to the intended 
recipient, you are hereby notified that any dissemination, distribution, or 
copying of this communication is strictly prohibited. If you have received this 
communication in error, please notify the Sender immediately by a "reply to 
sender only" message and destroy all electronic or paper copies of the 
communication, including any attachments.
_______________________________________________
Sepsisgroups mailing list
[email protected]
http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org

Reply via email to